Organoids: Current Implications and Pharmaceutical Applications in Liver Diseases

被引:3
|
作者
Zhu, Mengqi [1 ]
Huang, Yuting [2 ]
Bian, Saiyan [1 ]
Song, Qianqian [3 ]
Zhang, Jie [1 ]
Zheng, Wenjie [1 ]
Cheng, Chun [2 ]
机构
[1] Nantong Univ, Res Ctr Clin Med, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China
[2] Nantong Univ, Med Sch, 19 Qixiu Rd, Nantong 226001, Peoples R China
[3] Wake Forest Sch Med, Dept Radiol, One Med Ctr Blvd, Winston Salem, NC 27157 USA
关键词
Liver organoids; pharmaceutical model; three-dimensional culture; liver diseases; epidermal growth factor; stem cells; HEPATIC STELLATE CELLS; STEM-CELLS; IN-VITRO; SELF-ORGANIZATION; CULTURE; MOUSE; BUILD; ACT; ORGANOGENESIS; REGENERATION;
D O I
10.2174/1874467213666201217115854
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Understanding organogenesis, disorders, and repairing processes is particularly important for understanding the disease occurrence and developing treatment approaches. At present, liver-related studies are mainly conducted using in vivo models and cell lines, making it difficult to generalize the full picture of the structural characteristics and functions of human organs. Organoid is a three-dimensional (3D) culture system in vitro, which holds the promise to establish various disease models and conduct in-depth research by generating organ-like tissues in a dish. Recent advances in human liver organoids have provided a deeper understanding of this complex organ. In this review, we provide a systematic overview of the construction methods of organoids, focusing on their applications in the hepatic organogenesis and various liver disease models, as well as the limitations of current models. The development of organoid models is proving to be crucial in future liver research.
引用
收藏
页码:498 / 508
页数:11
相关论文
共 50 条
  • [31] Tumor organoids for primary liver cancers: A systematic review of current applications in diagnostics, disease modeling, and drug screening
    Qureshi, Ayesha A.
    Wehrle, Chase J.
    Ferreira-Gonzalez, Sofia
    Jiao, Chunbao
    Hong, Hanna
    Dadgar, Neda
    Arpi-Palacios, Jorge
    Phong, Yee Phoon
    Kim, Jaekeun
    Sun, Keyue
    Hashimoto, Koji
    Kwon, David C. H.
    Miller, Charles
    Leipzig, Nic
    Ma, Wen Wee
    Melenhorst, Jos
    Aucejo, Federico
    Schlegel, Andrea
    JHEP REPORTS, 2024, 6 (12)
  • [32] Implications of vanadium in technical applications and pharmaceutical issues
    Rehder, Dieter
    INORGANICA CHIMICA ACTA, 2017, 455 : 378 - 389
  • [33] Applications of Fluorescence Detection in Current Pharmaceutical Research
    Wada, Mitsuhiro
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2023, 71 (01) : 9 - 9
  • [34] The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases
    Nikokiraki, Christina
    Psaraki, Adriana
    Roubelakis, Maria G.
    CELLS, 2022, 11 (09)
  • [35] Research mechanisms of and pharmaceutical treatments for ferroptosis in liver diseases
    Yu, Jun
    Wang, Jian-qing
    BIOCHIMIE, 2021, 180 : 149 - 157
  • [36] IMPLICATIONS OF CURRENT RESEARCH ON METABOLIC DISEASES
    不详
    BRITISH VETERINARY JOURNAL, 1964, 120 (02): : 55 - &
  • [37] Hepatocyte-like cells and liver organoids: the application of iPSCs and their derivants for treating liver diseases
    Ju, Ruobing
    Tian, Siyuan
    Shang, Yulong
    Ma, Shuoyi
    Zhang, Miao
    Liu, Jingyi
    Sun, Keshuai
    Cui, Lina
    Zhou, Xia
    Han, Ying
    MATERIALS ADVANCES, 2024, 5 (21): : 8419 - 8431
  • [38] Current trend: Alcoholic liver diseases
    Naveau, S
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (04): : 550 - 553
  • [39] Management of liver diseases: Current perspectives
    Ray, Gautam
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (40) : 5818 - 5826
  • [40] Management of liver diseases: Current perspectives
    Gautam Ray
    World Journal of Gastroenterology, 2022, 28 (40) : 5818 - 5826